We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Essential Amino Acids Associated With Complications in Liver Transplant Recipients

By LabMedica International staff writers
Posted on 02 Mar 2022

End stage liver disease is a major cause of morbidity and mortality worldwide and orthotopic liver transplantation (OLTx) is the only curative treatment. More...

However, OLTx leads to its own risks and adverse sequelae.

The role of amino acids and their metabolism have recently gained more attention in this field of study. Specifically, branched-chain amino acids (BCAA) have repeatedly been associated with multiple cardiovascular and cardiometabolic morbidities that are observed in liver transplant recipients.

Hepatologists at the University Medical Center Groningen (Groningen, The Netherlands) and their colleagues performed a cross-sectional analysis of patients in a liver transplant subgroup and data from 336 participants were eligible for the study. The study group had a median age of 59 (IQR 46.0-67.0) years and was predominantly male (n=157; 57%). Data was collected between June 2015 and September 2019. During visits at the outpatient clinic, questionnaires, blood samples, 24-hour urine, feces, nails and hair were collected from all participants according to the TransplantLines protocol. Tissue samples and transplant biopsies were taken during transplant surgery.

Blood samples were drawn after an overnight fasting period of 8-12 hours and 24-hour urine specimens were collected at the same time. C-reactive protein (CRP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), albumin, HbA1c, fasting glucose, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides (TG), cytomegalovirus (CMV), Epstein Barr virus (EBV), eGFR, 24-hour urine protein and creatinine clearance were analyzed with standardized laboratory measurements.

Valine, leucine and isoleucine concentrations were measured in EDTA anti-coagulated plasma samples using a Vantera Clinical Analyzer (Labcorp, Morrisville, NC, USA), a fully automated, high-throughput, 400 MHz proton (1H) nuclear magnetic resonance (NMR) spectroscopy platform; in a standalone assay that has been optimized to quantify BCAA concentrations. BCAA quantified from the same samples using NMR and LC-MS/MS were highly correlated.

The investigators reported that the median of the total BCAA values was 358.5 (IQR 298.5-407.5) µmol/L in males and 300.0 (IQR 268.0-351.0) µmol/L in females. Patients in the highest tertile of BCAA values were more likely to have a higher BMI, higher systolic blood pressure, and higher prevalence of type 2 diabetes (T2D), high blood pressure and Metabolic Syndrome (MetS). Additionally, subjects with higher BCAA values had higher TG and lower HDL-cholesterol concentrations. Elevated HbA1c and fasting glucose values were also more frequently present in patients with higher BCAA values, while their eGFR was lower. In patients with viral liver disease a significant correlation with BCAA plasma levels could be observed in the total population, the group without metabolic syndrome and the T2D subgroup.

The authors concluded that elevated BCAA plasma levels are associated with T2D, MetS and the use of Sirolimus in stable OLTx recipients. BCAA plasma levels may be considered a biomarker that reflects an unfavorable metabolic status in liver transplant recipients. The study was published on February 7, 2022 in the journal Clinical Biochemistry.
 

Related Links:
University Medical Center Groningen
Labcorp


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Candida Glabrata Test
ELIchrom Glabrata
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.